Effects of vasoconstrictors during liver transplantatio
Not Applicable
Completed
- Conditions
- Not Applicable
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
liver transplant recipients with a systemic vascular resistance index < 1700 dyne·s·cm-5·m-2, pulmonary vascular resistance index < 150 dyne·s·cm-5·m-2
Exclusion Criteria
history of angina or myocardial infarction
evidence of cardiac decompensation
severe hemodynamic instability
preoperative vasopressor administration
primary renal dysfunction or hepatorenal syndrome
retransplantation
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Phenylephrine mechanism action hemodynamics acid-base tissue oxygenation during liver transplantation surgery
Comparative effectiveness phenylephrine norepinephrine vasopressin liver transplant hemodynamic stability outcomes
Biomarkers predicting phenylephrine response hemodynamic instability graft function liver transplantation
Phenylephrine infusion adverse events arrhythmias graft perfusion complications liver transplantation
Perioperative vasoconstrictor protocols hemodynamic management living donor liver transplantation outcomes